Journal of Psychopharmacology

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

SAGETRACK

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gorenstein, C.
Right arrow Articles by Marcourakis, T.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Gorenstein, C.
Right arrow Articles by Marcourakis, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Journal of Psychopharmacology, Vol. 9, No. 4, 313-318 (1995)
DOI: 10.1177/026988119500900404

Impairment of performance associated with long-term use of benzodiazepines

C. Gorenstein

Departamento de Farmacologia, Instituto de Ciências Biomédicas and LIM-23 Faculdade de Medicina

M.A. Bernik

Instituto de Psiquiatria, Hospital das Clínicas, Faculdade de Medicina

S. Pompéia

Núcleo de Neurociências e Comportamento, Universidade de São Paulo, Brazil

T. Marcourakis

Departamento de Farmacologia, Instituto de Ciências Biomédicas and LIM-23 Faculdade de Medicina

The long-term effects of benzodiazepines (BDZ) on psychomotor and cognitive functions were assessed in 28 out patients, users of low therapeutic doses of diazepam (13.6 ± 4.9 mg/day, range: 5-20 mg/day) for 5-20 years (10.1 ± 5.0 years). These patients' performance was compared with two control groups: 53 BDZ-free anxious out patients and 56 healthy volunteers. The three groups were similar in sex, age and education. BDZ chronic users were tested before and after short-term (3 weeks) and long-term discontinuation (at an average of 10 months). Performance of chronic users of BDZ was consistently worse than those of the control groups, suggesting an impairment in these patients on both psychomotor and cognitive functions. These were not related to either dose or cumulative exposure to BDZ, and were also independent of diagnosis and levels of anxiety and depression. Moreover, these deficits were persistent as their performance failed to improve after drug discontinuation.

Key Words: benzodiazepines • memory • psychomotor performance • chronic use • impairment • anxiety disorder


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?